These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10729169)

  • 61. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product.
    Wilk T; Pfeiffer T; Bosch V
    Virology; 1992 Jul; 189(1):167-77. PubMed ID: 1604808
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.
    Chan WE; Lin HH; Chen SS
    J Virol; 2005 Jul; 79(13):8374-87. PubMed ID: 15956582
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits.
    Sanders RW; Schiffner L; Master A; Kajumo F; Guo Y; Dragic T; Moore JP; Binley JM
    J Virol; 2000 Jun; 74(11):5091-100. PubMed ID: 10799583
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
    Wang BZ; Liu W; Kang SM; Alam M; Huang C; Ye L; Sun Y; Li Y; Kothe DL; Pushko P; Dokland T; Haynes BF; Smith G; Hahn BH; Compans RW
    J Virol; 2007 Oct; 81(20):10869-78. PubMed ID: 17670815
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter].
    Wyss S; Berlioz-Torrent C; Boge M; Blot G; Höning S; Benarous R; Thali M
    J Virol; 2001 Mar; 75(6):2982-92. PubMed ID: 11222723
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.
    Abada P; Noble B; Cannon PM
    J Virol; 2005 Mar; 79(6):3627-38. PubMed ID: 15731257
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
    Fenouillet E; Jones IM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.
    Cantin R; Fortin JF; Lamontagne G; Tremblay M
    J Virol; 1997 Mar; 71(3):1922-30. PubMed ID: 9032323
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection.
    Lawn SD; Butera ST
    J Virol; 2000 Nov; 74(21):10256-9. PubMed ID: 11024159
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study.
    Meerloo T; Parmentier HK; Osterhaus AD; Goudsmit J; Schuurman HJ
    AIDS; 1992 Oct; 6(10):1105-16. PubMed ID: 1466841
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis.
    Schols D; Pauwels R; Desmyter J; De Clercq E
    Virology; 1992 Jul; 189(1):374-6. PubMed ID: 1604822
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein.
    Emerson V; Holtkotte D; Pfeiffer T; Wang IH; Schnölzer M; Kempf T; Bosch V
    J Virol; 2010 Feb; 84(3):1355-65. PubMed ID: 19906925
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity.
    Asmal M; Hellmann I; Liu W; Keele BF; Perelson AS; Bhattacharya T; Gnanakaran S; Daniels M; Haynes BF; Korber BT; Hahn BH; Shaw GM; Letvin NL
    PLoS One; 2011; 6(8):e23673. PubMed ID: 21876761
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glucose-dependent aerobic glycolysis contributes to recruiting viral components into HIV-1 particles to maintain infectivity.
    Kishimoto N; Yamamoto K; Abe T; Yasuoka N; Takamune N; Misumi S
    Biochem Biophys Res Commun; 2021 Apr; 549():187-193. PubMed ID: 33676187
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane.
    Finzi A; Perlman M; Bourgeois-Daigneault MC; Thibodeau J; Cohen ÉA
    Cell Microbiol; 2013 May; 15(5):809-22. PubMed ID: 23170932
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ubiquitination of the human immunodeficiency virus type 1 env glycoprotein.
    Bültmann A; Eberle J; Haas J
    J Virol; 2000 Jun; 74(11):5373-6. PubMed ID: 10799617
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface.
    Center RJ; Leapman RD; Lebowitz J; Arthur LO; Earl PL; Moss B
    J Virol; 2002 Aug; 76(15):7863-7. PubMed ID: 12097599
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Detection of antibodies to HIV-1 gp41- and HLA class II antigen-derived peptides in SLE patients.
    Koshino K; Tokano Y; Hishikawa T; Sekigawa I; Takasaki Y; Hashimoto H
    Scand J Rheumatol; 1995; 24(5):288-92. PubMed ID: 8533043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.